{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:03:21Z","timestamp":1784642601090,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K10230"],"award-info":[{"award-number":["22K10230"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bone.2024.117323","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T18:52:32Z","timestamp":1730832752000},"page":"117323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Extracellular vesicles from mouse bone marrow macrophages-derived osteoclasts treated with zoledronic acid contain miR-146a-5p and miR-322-3p, which inhibit osteoclast function"],"prefix":"10.1016","volume":"190","author":[{"given":"Sakura","family":"Minami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Hatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ochiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Chikazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bone.2024.117323_bb0005","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"1","key":"10.1016\/j.bone.2024.117323_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-224455","article-title":"Medication-related osteonecrosis (MRONJ) of the mandible and maxilla","volume":"13","author":"Dunphy","year":"2020","journal-title":"BMJ Case Rep."},{"issue":"4","key":"10.1016\/j.bone.2024.117323_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.8788","article-title":"Medication-related osteonecrosis of the jaw: case series and literature review","volume":"12","author":"Kimathi","year":"2024","journal-title":"Clin Case Rep"},{"issue":"5","key":"10.1016\/j.bone.2024.117323_bb0020","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the Jaws-2022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"3","key":"10.1016\/j.bone.2024.117323_bb0025","first-page":"202","article-title":"Medication-related osteonecrosis of the jaw (MRONJ): a review of pathophysiology","volume":"34","author":"AlRowis","year":"2022","journal-title":"Risk Factors, Preventive Measures and Treatment Strategies, Saudi Dent J"},{"issue":"5","key":"10.1016\/j.bone.2024.117323_bb0030","article-title":"Various therapeutic methods for the treatment of medication-related osteonecrosis of the jaw (MRONJ) and their limitations: a","volume":"10","author":"On","year":"2021","journal-title":"Narrative Review on New Molecular and Cellular Therapeutic Approaches, Antioxidants (Basel)"},{"issue":"5","key":"10.1016\/j.bone.2024.117323_bb0035","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00784-014-1320-4","article-title":"Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation","volume":"19","author":"Hagelauer","year":"2015","journal-title":"Clin. Oral Investig."},{"issue":"1","key":"10.1016\/j.bone.2024.117323_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2024.117323_bb0045","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2019.02.029","article-title":"Reassessment of exosome composition","volume":"177","author":"Jeppesen","year":"2019","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bone.2024.117323_bb0050","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bone.2024.117323_bb0055","doi-asserted-by":"crossref","first-page":"10872","DOI":"10.1038\/ncomms10872","article-title":"Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation","volume":"7","author":"Li","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bone.2024.117323_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110319","article-title":"BMSC-derived extracellular vesicles promoted osteogenesis via Axin2 inhibition by delivering MiR-16-5p","volume":"120","author":"Duan","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.bone.2024.117323_bb0065","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1007\/s10528-023-10569-5","article-title":"Extracellular vesicles from human adipose tissue-derived mesenchymal stem cells suppress RANKL-Induced osteoclast differentiation via miR122-5p","volume":"62","author":"Choi","year":"2024","journal-title":"Biochem. Genet."},{"issue":"3","key":"10.1016\/j.bone.2024.117323_bb0070","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/jcp.24916","article-title":"Dual effect of Cyanidin on RANKL-induced differentiation and fusion of osteoclasts","volume":"231","author":"Dou","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bone.2024.117323_bb0075","article-title":"Improving reproducibility to meet minimal information for studies of extracellular vesicles 2018 guidelines in nanoparticle tracking analysis","volume":"177","author":"Snyder","year":"2021","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bone.2024.117323_bb0080","doi-asserted-by":"crossref","first-page":"27031","DOI":"10.3402\/jev.v4.27031","article-title":"Optimized exosome isolation protocol for cell culture supernatant and human plasma","volume":"4","author":"Lobb","year":"2015","journal-title":"J Extracell Vesicles"},{"issue":"7","key":"10.1016\/j.bone.2024.117323_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107487","article-title":"14-3-3\u03b6 suppresses RANKL signaling by destabilizing TRAF6","volume":"300","author":"Ayyasamy","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bone.2024.117323_bb0090","doi-asserted-by":"crossref","first-page":"2193280","DOI":"10.1080\/21623945.2023.2193280","article-title":"TRAF6 promotes osteogenesis in ADSCs through Raf-Erk-Merk-Hif1-a pathway","volume":"12","author":"Liu","year":"2023","journal-title":"Adipocyte"},{"issue":"2","key":"10.1016\/j.bone.2024.117323_bb0095","first-page":"582","article-title":"Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-\u03baB and JNK signalling pathways","volume":"44","author":"Huang","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"14","key":"10.1016\/j.bone.2024.117323_bb0100","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.7150\/ijms.27593","article-title":"Circulating microRNA panel as a novel biomarker to diagnose bisphosphonate-related osteonecrosis of the jaw","volume":"15","author":"Yang","year":"2018","journal-title":"Int. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.bone.2024.117323_bb0105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/ijms17030349","article-title":"MicroRNAs in Osteoclastogenesis and function: potential therapeutic targets for osteoporosis","volume":"17","author":"Ji","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bone.2024.117323_bb0110","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/art.30321","article-title":"The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis","volume":"63","author":"Nakasa","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.bone.2024.117323_bb0115","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.7150\/thno.58731","article-title":"Extracellular vesicles derived from M1 macrophages deliver miR-146a-5p and miR-146b-5p to suppress trophoblast migration and invasion by targeting TRAF6 in recurrent spontaneous abortion","volume":"11","author":"Ding","year":"2021","journal-title":"Theranostics"},{"issue":"34","key":"10.1016\/j.bone.2024.117323_bb0120","doi-asserted-by":"crossref","first-page":"11836","DOI":"10.1021\/bi981067q","article-title":"CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization","volume":"37","author":"Pullen","year":"1998","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.bone.2024.117323_bb0125","doi-asserted-by":"crossref","first-page":"623","DOI":"10.4049\/jimmunol.164.2.623","article-title":"Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions","volume":"164","author":"Jalukar","year":"2000","journal-title":"J. Immunol."},{"issue":"32","key":"10.1016\/j.bone.2024.117323_bb0130","doi-asserted-by":"crossref","first-page":"22414","DOI":"10.1074\/jbc.274.32.22414","article-title":"Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation","volume":"274","author":"Leo","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bone.2024.117323_bb0135","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0092-8674(94)90532-0","article-title":"A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor","volume":"78","author":"Rothe","year":"1994","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bone.2024.117323_bb0140","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4161\/cc.5.8.2637","article-title":"TRAF3: a new regulator of type I interferons","volume":"5","author":"Saha","year":"2006","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.bone.2024.117323_bb0145","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.molcel.2013.07.014","article-title":"TRAF4 promotes TGF-\u03b2 receptor signaling and drives breast cancer metastasis","volume":"51","author":"Zhang","year":"2013","journal-title":"Mol. Cell"},{"issue":"18","key":"10.1016\/j.bone.2024.117323_bb0150","doi-asserted-by":"crossref","first-page":"9437","DOI":"10.1073\/pnas.93.18.9437","article-title":"TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling","volume":"93","author":"Ishida","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6599","key":"10.1016\/j.bone.2024.117323_bb0155","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/383443a0","article-title":"TRAF6 is a signal transducer for interleukin-1","volume":"383","author":"Cao","year":"1996","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bone.2024.117323_bb0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ncb1086","article-title":"A physical and functional map of the human TNF-alpha\/NF-kappa B signal transduction pathway","volume":"6","author":"Bouwmeester","year":"2004","journal-title":"Nat. Cell Biol."},{"issue":"8","key":"10.1016\/j.bone.2024.117323_bb0165","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1101\/gad.13.8.1015","article-title":"TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling","volume":"13","author":"Lomaga","year":"1999","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.bone.2024.117323_bb0170","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ni1118","article-title":"Interferon-alpha induction through toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6","volume":"5","author":"Kawai","year":"2004","journal-title":"Nat. Immunol."},{"issue":"20","key":"10.1016\/j.bone.2024.117323_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/cells12202430","article-title":"Denosumab and Zoledronic acid differently affect circulating immune subsets: a possible role in the onset of MRONJ","volume":"12","author":"Roato","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bone.2024.117323_bb0180","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41420-023-01492-0","article-title":"MiR-146a-5p deficiency in extracellular vesicles of glioma-associated macrophages promotes epithelial-mesenchymal transition through the NF-\u03baB signaling pathway","volume":"9","author":"Xu","year":"2023","journal-title":"Cell Death Discov"},{"issue":"1","key":"10.1016\/j.bone.2024.117323_bb0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0092-8674(01)00622-5","article-title":"The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation","volume":"108","author":"Nakashima","year":"2002","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bone.2024.117323_bb0190","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.oooo.2018.09.008","article-title":"Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment","volume":"127","author":"Nicolatou-Galitis","year":"2019","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328224003120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328224003120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T04:12:47Z","timestamp":1735445567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328224003120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":38,"alternative-id":["S8756328224003120"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2024.117323","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular vesicles from mouse bone marrow macrophages-derived osteoclasts treated with zoledronic acid contain miR-146a-5p and miR-322-3p, which inhibit osteoclast function","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2024.117323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117323"}}